HOPKINTON, Mass., Nov. 29 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. today announced that it will participate in Deutsche Bank’s Healthcare Technology Industry Day at The Hilton Boston Financial District Hotel on December 6, 2007. Kevin Hrusovsky, President and CEO of Caliper, will participate in a day of one-on-one meetings with institutional investors. These meetings are not webcast; however a copy of the Corporate Presentation, which will be used in these meetings, will be available on the Caliper website at http://www.caliperLS.com.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper’s portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions.
CONTACT: Tom Higgins, CFO of Caliper Life Sciences, Inc., +1-508-497-2809
Web site: http://www.caliperls.com/
